In GBM, CXCR4 and CXCL12 are overexpressed in tumor tissue when compared with normal adjacent parenchyma, and their expression level is correlated with tumor grade and poor prognosis (Salmaggi et al., 2005a; Bian et al., 2007). The gene discussed is CXCR4; the disease is glioblastoma.